Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth

被引:225
作者
Schouten, O.
van Laanen, J. H. H.
Boersma, E.
Vidakovic, R.
Feringa, H. H. H.
Dunkelgrun, M.
Bax, J. J.
Koning, J.
van Urk, H.
Poldermans, D.
机构
[1] Erasmus Univ, Dept Vasc Surg, Med Ctr, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Cardiol, Rotterdam, Netherlands
[3] Reinier Graaf Gasthuis, Dept Surg, Delft, Netherlands
[4] Dedinje Cardiovasc Inst, Dept Cardiol, Belgrade, Serbia Monteneg
[5] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands
关键词
abdominal aortic aneurysm; growth; statins;
D O I
10.1016/j.ejvs.2005.12.024
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective. To evaluate the effect of statins on aneurysm growth in a group of consecutive patients under surveillance for infrarenal aortic aneurysms (AAA). Materials and methods. All patients (59 statin users, 91 non-users) under surveillance between January 2002 and August 2005 with a follow-up for aneurysm growth of at least 12 months and a minimum of three diameter evaluations were retrospectively included in the analysis. Multiple regression analysis, weighted with the number of observations, was performed to test the influence of statins on AAA growth rate. Results. During a median period of 3.1 (1.1-13.1) years the overall mean aneurysm growth rate was 2.95 +/- 2.8 mm/year. Statin users had a 1.16 mm/year lower AAA growth rate compared to non-users (95% CI 0.33-1.99 mm/year). Increased age was associated with a slower growth (- 0.09 mm/year per year, p = 0.003). Female gender (+ 1.82 mm/year, p = 0.008) and aneurysm diameter (+ 0.06 mm/year per mm, p = 0.049) were associated with increased AAA growth. The use of nonsteroidal anti-inflammatory drugs, chronic lung disease, or other cardiovascular risk factors were not independently associated with AAA growth. Conclusions. Statins appear to be associated with attenuation of AAA growth, irrespective of other known factors influencing aneurysm growth.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 33 条
[1]  
Aikawa M, 2001, CIRCULATION, V103, P276
[2]   Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms [J].
Annabi, B ;
Shédid, D ;
Ghosn, P ;
Kenigsberg, RL ;
Desrosiers, RR ;
Bojanowski, MW ;
Beaulieu, É ;
Nassif, E ;
Moumdjian, R ;
Béliveau, R .
JOURNAL OF VASCULAR SURGERY, 2002, 35 (03) :539-546
[3]  
Ashton H, 2001, J MED SCREEN, V8, P46
[4]   The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial [J].
Ashton, HA ;
Buxton, MJ ;
Day, NE ;
Kim, LG ;
Marteau, TM ;
Scott, RAP ;
Thomspon, SG ;
Walker, NM .
LANCET, 2002, 360 (9345) :1531-1539
[5]   Interleukin-6 -174G>C polymorphism and risk of coronary heart disease in West of Scotland Coronary Prevention Study (WOSCOPS) [J].
Basso, F ;
Lowe, GDO ;
Rumley, A ;
McMahon, AD ;
Humphries, SE .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) :599-604
[6]   Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: Report of a prospective (Phase II) multicenter study [J].
Baxter, BT ;
Pearce, WH ;
Waltke, EA ;
Littooy, FN ;
Hallett, JW ;
Kent, KC ;
Upchurch, GR ;
Chaikof, EL ;
Mills, JL ;
Fleckten, B ;
Longo, GM ;
Lee, JK ;
Thompson, RW .
JOURNAL OF VASCULAR SURGERY, 2002, 36 (01) :1-12
[7]   HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages [J].
Bellosta, S ;
Via, D ;
Canavesi, M ;
Pfister, P ;
Fumagalli, R ;
Paoletti, R ;
Bernini, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (11) :1671-1678
[8]   Abdominal aortic aneurysm expansion - Risk factors and time intervals for surveillance [J].
Brady, AR ;
Thompson, SG ;
Fowkes, FGR ;
Greenhalgh, RM ;
Powell, JT .
CIRCULATION, 2004, 110 (01) :16-21
[9]  
Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5
[10]   Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context? [J].
Curci, JA ;
Thompson, RW .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :168-171